COVID-19 Impact on Global Adoptive Cell Therapy Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Adoptive Cell Therapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CAR-T
1.4.3 TCR-T
1.4.4 NK
1.4.5 TIL
1.5 Market by Application
1.5.1 Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Lymphoma
1.5.3 Leukemia
1.6 Coronavirus Disease 2019 (Covid-19): Adoptive Cell Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Adoptive Cell Therapy Industry
1.6.1.1 Adoptive Cell Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Adoptive Cell Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Adoptive Cell Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Adoptive Cell Therapy Market Perspective (2015-2026)
2.2 Adoptive Cell Therapy Growth Trends by Regions
2.2.1 Adoptive Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Adoptive Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Adoptive Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Adoptive Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Adoptive Cell Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Therapy Players by Market Size
3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adoptive Cell Therapy Market Concentration Ratio
3.2.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2019
3.3 Adoptive Cell Therapy Key Players Head office and Area Served
3.4 Key Players Adoptive Cell Therapy Product Solution and Service
3.5 Date of Enter into Adoptive Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Adoptive Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Adoptive Cell Therapy Market Size by Application (2015-2020)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Adoptive Cell Therapy Market Size (2015-2020)
6.2 Adoptive Cell Therapy Key Players in North America (2019-2020)
6.3 North America Adoptive Cell Therapy Market Size by Type (2015-2020)
6.4 North America Adoptive Cell Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size (2015-2020)
7.2 Adoptive Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Adoptive Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Adoptive Cell Therapy Market Size by Application (2015-2020)
8 China
8.1 China Adoptive Cell Therapy Market Size (2015-2020)
8.2 Adoptive Cell Therapy Key Players in China (2019-2020)
8.3 China Adoptive Cell Therapy Market Size by Type (2015-2020)
8.4 China Adoptive Cell Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Adoptive Cell Therapy Market Size (2015-2020)
9.2 Adoptive Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Adoptive Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Adoptive Cell Therapy Market Size by Application (2015-2020)
10 South Korea
10.1 South Korea Adoptive Cell Therapy Market Size (2015-2020)
10.2 Adoptive Cell Therapy Key Players in South Korea (2019-2020)
10.3 South Korea Adoptive Cell Therapy Market Size by Type (2015-2020)
10.4 South Korea Adoptive Cell Therapy Market Size by Application (2015-2020)
11 India
11.1 India Adoptive Cell Therapy Market Size (2015-2020)
11.2 Adoptive Cell Therapy Key Players in India (2019-2020)
11.3 India Adoptive Cell Therapy Market Size by Type (2015-2020)
11.4 India Adoptive Cell Therapy Market Size by Application (2015-2020)
12 Key Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Novartis Business Overview and Its Total Revenue
12.1.3 Novartis Adoptive Cell Therapy Introduction
12.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2015-2020))
12.1.5 Novartis Recent Development
12.2 Juno
12.2.1 Juno Company Details
12.2.2 Juno Business Overview and Its Total Revenue
12.2.3 Juno Adoptive Cell Therapy Introduction
12.2.4 Juno Revenue in Adoptive Cell Therapy Business (2015-2020)
12.2.5 Juno Recent Development
12.3 Kite
12.3.1 Kite Company Details
12.3.2 Kite Business Overview and Its Total Revenue
12.3.3 Kite Adoptive Cell Therapy Introduction
12.3.4 Kite Revenue in Adoptive Cell Therapy Business (2015-2020)
12.3.5 Kite Recent Development
12.4 Adaptimmune
12.4.1 Adaptimmune Company Details
12.4.2 Adaptimmune Business Overview and Its Total Revenue
12.4.3 Adaptimmune Adoptive Cell Therapy Introduction
12.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2015-2020)
12.4.5 Adaptimmune Recent Development
12.5 Fibrocell
12.5.1 Fibrocell Company Details
12.5.2 Fibrocell Business Overview and Its Total Revenue
12.5.3 Fibrocell Adoptive Cell Therapy Introduction
12.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2015-2020)
12.5.5 Fibrocell Recent Development
12.6 Lineage Cell Therapeutics
12.6.1 Lineage Cell Therapeutics Company Details
12.6.2 Lineage Cell Therapeutics Business Overview and Its Total Revenue
12.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
12.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2015-2020)
12.6.5 Lineage Cell Therapeutics Recent Development
12.7 BioTime
12.7.1 BioTime Company Details
12.7.2 BioTime Business Overview and Its Total Revenue
12.7.3 BioTime Adoptive Cell Therapy Introduction
12.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2015-2020)
12.7.5 BioTime Recent Development
12.8 Vericel Corporation
12.8.1 Vericel Corporation Company Details
12.8.2 Vericel Corporation Business Overview and Its Total Revenue
12.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
12.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2015-2020)
12.8.5 Vericel Corporation Recent Development
12.9 Regeneus
12.9.1 Regeneus Company Details
12.9.2 Regeneus Business Overview and Its Total Revenue
12.9.3 Regeneus Adoptive Cell Therapy Introduction
12.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2015-2020)
12.9.5 Regeneus Recent Development
12.10 Anhui Anke Biotechnology
12.10.1 Anhui Anke Biotechnology Company Details
12.10.2 Anhui Anke Biotechnology Business Overview and Its Total Revenue
12.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
12.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2015-2020)
12.10.5 Anhui Anke Biotechnology Recent Development
12.11 Cellectis
10.11.1 Cellectis Company Details
10.11.2 Cellectis Business Overview and Its Total Revenue
10.11.3 Cellectis Adoptive Cell Therapy Introduction
10.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2015-2020)
10.11.5 Cellectis Recent Development
12.12 NantKwest
10.12.1 NantKwest Company Details
10.12.2 NantKwest Business Overview and Its Total Revenue
10.12.3 NantKwest Adoptive Cell Therapy Introduction
10.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2015-2020)
10.12.5 NantKwest Recent Development
12.13 SorrentoTherapeutics
10.13.1 SorrentoTherapeutics Company Details
10.13.2 SorrentoTherapeutics Business Overview and Its Total Revenue
10.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
10.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2015-2020)
10.13.5 SorrentoTherapeutics Recent Development
12.14 Bellicum
10.14.1 Bellicum Company Details
10.14.2 Bellicum Business Overview and Its Total Revenue
10.14.3 Bellicum Adoptive Cell Therapy Introduction
10.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2015-2020)
10.14.5 Bellicum Recent Development
13 Analyst's Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
14.3 Author Details
List of Tables
Table 1. Adoptive Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Adoptive Cell Therapy Revenue
Table 3. Ranking of Global Top Adoptive Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CAR-T
Table 6. Key Players of TCR-T
Table 7. Key Players of NK
Table 8. Key Players of TIL
Table 9. COVID-19 Impact Global Market: (Four Adoptive Cell Therapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Adoptive Cell Therapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Adoptive Cell Therapy Players to Combat Covid-19 Impact
Table 14. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Adoptive Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Adoptive Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Adoptive Cell Therapy Market Share by Regions (2015-2020)
Table 18. Global Adoptive Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Adoptive Cell Therapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Adoptive Cell Therapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Adoptive Cell Therapy Players
Table 25. Global Adoptive Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Adoptive Cell Therapy Market Share by Players (2015-2020)
Table 27. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2019)
Table 28. Global Adoptive Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Adoptive Cell Therapy Product Solution and Service
Table 31. Date of Enter into Adoptive Cell Therapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 34. Global Adoptive Cell Therapy Market Size Share by Type (2015-2020)
Table 35. Global Adoptive Cell Therapy Revenue Market Share by Type (2021-2026)
Table 36. Global Adoptive Cell Therapy Market Size Share by Application (2015-2020)
Table 37. Global Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Adoptive Cell Therapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 41. North America Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 42. North America Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 43. North America Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 47. Europe Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 49. Europe Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 51. China Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 52. China Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 53. China Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 54. China Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 55. China Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. China Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 57. Japan Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 59. Japan Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 61. Japan Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 63. South Korea Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 64. South Korea Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 65. South Korea Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 66. South Korea Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 67. South Korea Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 68. South Korea Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 69. India Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 70. India Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 71. India Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 72. India Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 73. India Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 74. India Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Product
Table 78. Novartis Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 79. Novartis Recent Development
Table 80. Juno Company Details
Table 81. Juno Business Overview
Table 82. Juno Product
Table 83. Juno Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 84. Juno Recent Development
Table 85. Kite Company Details
Table 86. Kite Business Overview
Table 87. Kite Product
Table 88. Kite Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 89. Kite Recent Development
Table 90. Adaptimmune Company Details
Table 91. Adaptimmune Business Overview
Table 92. Adaptimmune Product
Table 93. Adaptimmune Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 94. Adaptimmune Recent Development
Table 95. Fibrocell Company Details
Table 96. Fibrocell Business Overview
Table 97. Fibrocell Product
Table 98. Fibrocell Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 99. Fibrocell Recent Development
Table 100. Lineage Cell Therapeutics Company Details
Table 101. Lineage Cell Therapeutics Business Overview
Table 102. Lineage Cell Therapeutics Product
Table 103. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 104. Lineage Cell Therapeutics Recent Development
Table 105. BioTime Company Details
Table 106. BioTime Business Overview
Table 107. BioTime Product
Table 108. BioTime Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 109. BioTime Recent Development
Table 110. Vericel Corporation Business Overview
Table 111. Vericel Corporation Product
Table 112. Vericel Corporation Company Details
Table 113. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 114. Vericel Corporation Recent Development
Table 115. Regeneus Company Details
Table 116. Regeneus Business Overview
Table 117. Regeneus Product
Table 118. Regeneus Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 119. Regeneus Recent Development
Table 120. Anhui Anke Biotechnology Company Details
Table 121. Anhui Anke Biotechnology Business Overview
Table 122. Anhui Anke Biotechnology Product
Table 123. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 124. Anhui Anke Biotechnology Recent Development
Table 125. Cellectis Company Details
Table 126. Cellectis Business Overview
Table 127. Cellectis Product
Table 128. Cellectis Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 129. Cellectis Recent Development
Table 130. NantKwest Company Details
Table 131. NantKwest Business Overview
Table 132. NantKwest Product
Table 133. NantKwest Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 134. NantKwest Recent Development
Table 135. SorrentoTherapeutics Company Details
Table 136. SorrentoTherapeutics Business Overview
Table 137. SorrentoTherapeutics Product
Table 138. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 139. SorrentoTherapeutics Recent Development
Table 140. Bellicum Company Details
Table 141. Bellicum Business Overview
Table 142. Bellicum Product
Table 143. Bellicum Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 144. Bellicum Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. CAR-T Features
Figure 3. TCR-T Features
Figure 4. NK Features
Figure 5. TIL Features
Figure 6. Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2026
Figure 7. Lymphoma Case Studies
Figure 8. Leukemia Case Studies
Figure 9. Adoptive Cell Therapy Report Years Considered
Figure 10. Global Adoptive Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Adoptive Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 12. Global Adoptive Cell Therapy Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Adoptive Cell Therapy Market Share by Players in 2019
Figure 15. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2019
Figure 17. North America Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. South Korea Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 25. Juno Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 27. Kite Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 29. Adaptimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 31. Fibrocell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 33. Lineage Cell Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 35. BioTime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 37. Vericel Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 39. Regeneus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 41. Anhui Anke Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 43. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 45. NantKwest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 47. SorrentoTherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 49. Bellicum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs